Skip to main content

Table 1 Patient characteristics

From: Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer

Case

Age/sex

Site of recurrence

Tumor size (mm)

Time to recurrence (month)

Previous operation

Original stage

Original Tumor site

LN dissection

Original pathology

Adjuvant CT

1

59/M

head of pancreas

30

7

TG

T4N1M0

lower

D2

intestinal

yes

2

65/M

omental bursa

50

11

PG

T3N1M0

lower

D2

intestinal

yes

3

62/F

omental bursa

50

18

PG

T2N2M0

middle

D2

intestinal

yes

4

83/M

porta hepatis

25

32

PG

T2N1M0

lower

D1

intestinal

no

5

45/F

tail of pancreas

60

16

TG

T4N2M0

middle

D2

diffuse

yes

6

66/M

PALN

25

28

PG

T3N2M0

upper

D2

intestinal

yes

7

49/M

PALN

35

17

PG

T3N1M0

lower

D2

intestinal

yes

8

79 M

hilum of spleen

28

10

PG

T2N2M0

lower

D1

intestinal

yes

9

67/F

omental bursa

25

14

TG

T3N1M0

lower

D2

diffuse

yes

10

72/M

omental bursa

45

13

PG

T2N1M0

upper

D2

intestinal

no

11

49/M

head of pancreas

25

14

PG

T3N1M0

lower

D2

intestinal

yes

12

42/M

porta hepatis

40

16

PG

T3N1M0

middle

D2

diffuse

yes

13

66/M

porta hepatis

22

19

PG

T3N1M0

lower

D2

intestinal

yes

14

72/F

head of pancreas

38

10

TG

T4N1M0

lower

D1

diffuse

yes

15

63/M

PALN

20

26

PG

T2N1M0

upper

D2

intestinal

yes

16

70/M

omental bursa

26

18

TG

T4N0M0

lower

D2

diffuse

yes

17

62/F

omental bursa

55

24

PG

T3N1M0

middle

D2

intestinal

yes

18

45/F

tail of pancreas

43

20

PG

T2N2M0

lower

D2

intestinal

yes

19

55/F

PALN

52

16

PG

T1N2M0

upper

D1

intestinal

yes

20

58/M

PALN

22

30

PG

T3N1M0

lower

D2

intestinal

yes

21

71/M

hilum of spleen

45

9

TG

T$N2M0

lower

D2

diffuse

yes

22

62/F

omental bursa

48

24

TG

T3N1M0

middle

D2

intestinal

yes

23

45/M

PALN

25

23

PG

T2N1M0

lower

D2

intestinal

yes

24

68/F

tail of pancreas

38

32

PG

T2N1M0

lower

D2

intestinal

yes

25

71/M

PALN

35

36

PG

T2N1M0

upper

D2

intestinal

no

26

76/M

porta hepatis

22

24

PG

T4N0M0

upper

D1

intestinal

yes

27

49/F

omental bursa

30

11

TG

T3N2M0

middle

D2

diffuse

yes

28

79/M

PALN

20

14

PG

T3N1M0

lower

D1

intestinal

no

  1. PALN:para-aortic lymph node; TG: total gastrectomy; PG: partial gastrectomy; TNM stage: International Union Against Cancer (UICC 2002) TNM system; LN: lymph node; CT: chemotherapy.